Cargando…
YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma
BACKGROUND: Definitive chemoradiation therapy (dCRT) is the standard treatment for patients with nonsurgical esophageal squamous cell carcinoma (ESCC), yet patients have demonstrated great variations in their responses to dCRT and inevitably progressed following treatment. METHODS: To identify progn...
Autores principales: | Dai, Honghai, Shao, Yang W., Tong, Xiaoling, Wu, Xue, Pang, Jiaohui, Feng, Alei, Yang, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050074/ https://www.ncbi.nlm.nih.gov/pubmed/31851786 http://dx.doi.org/10.1002/cam4.2761 |
Ejemplares similares
-
Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with Chemoradiotherapy
por: Feng, Alei, et al.
Publicado: (2022) -
Pathway-Based Analysis Revealed the Role of Keap1-Nrf2 Pathway and PI3K-Akt Pathway in Chinese Esophageal Squamous Cell Carcinoma Patients With Definitive Chemoradiotherapy
por: Dai, Honghai, et al.
Publicado: (2022) -
Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging
por: Xu, Hongyao, et al.
Publicado: (2019) -
The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
por: Dreyfuss, Alexandra D., et al.
Publicado: (2021) -
SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma
por: Chai, Yuhang, et al.
Publicado: (2019)